BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Protelos strontium ranelate: Phase III data

A double-blind, international Phase III trial in 268 women with postmenopausal osteoporosis showed that once-daily 2 g oral Protelos met the primary endpoint of significantly increasing the proportion of bone surface on which new mineralized bone was deposited...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >